Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
18,309,601
-
Share change
-
-216,010
-
Total reported value
-
$2,504,507,593
-
Put/Call ratio
-
12%
-
Price per share
-
$136.72
-
Number of holders
-
225
-
Value change
-
-$30,813,593
-
Number of buys
-
110
-
Number of sells
-
98
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2016
As of 31 Mar 2016,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,309,601 shares.
The largest 10 holders included
ATLANTA CAPITAL MANAGEMENT CO L L C, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, ACADIAN ASSET MANAGEMENT LLC, LEVIN CAPITAL STRATEGIES, L.P., BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., WELLS FARGO & COMPANY/MN, STATE STREET CORP, and NWQ INVESTMENT MANAGEMENT COMPANY, LLC.
This page lists
225
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.